ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - epoetin beta 2000 iu / 0.3 ml - solution for injection - erythropoietin - treatment of anemia associated with chronic renal failure (renal anemia) in patients on dialysis. treatment of symptomatic renal anemia in patients not yet undergoing dialysis. increasing the yield of autologous blood from patients in a pre-donation program. its use in this indication must be balanced against the reported increased risk of thromboembolic events. treatment should only be given to patients with moderate anemia (hb 10-13 g/dl (6.21- 8.07 mmol/l) no iron deficiency) or when blood conserving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males). treatment of anemia in adult patients with solid tumors and treated with platinum-based chemotherapy prone to induce anemia (cisplatin 75 mg/m2/cycle carboplatin: 350 mg/m2/cycle). treatment of anemia in adult patients with multiple myeloma low grade non-hodgkin's lymphoma or chronic lymphocytic leukemia who have a relative

ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - epoetin beta 3000 iu / 0.3 ml - solution for injection - erythropoietin - treatment of anemia associated with chronic renal failure (renal anemia) in patients on dialysis. treatment of symptomatic renal anemia in patients not yet undergoing dialysis. increasing the yield of autologous blood from patients in a pre-donation program. its use in this indication must be balanced against the reported increased risk of thromboembolic events. treatment should only be given to patients with moderate anemia (hb 10-13 g/dl (6.21- 8.07 mmol/l) no iron deficiency) or when blood conserving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males). treatment of anemia in adult patients with solid tumors and treated with platinum-based chemotherapy prone to induce anemia (cisplatin 75 mg/m2/cycle carboplatin: 350 mg/m2/cycle). treatment of anemia in adult patients with multiple myeloma low grade non-hodgkin's lymphoma or chronic lymphocytic leukemia who have a relative

ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - methoxy polyethylene glycol-epoetin beta 30 mcg/ml / 0.3 ml - solution for injection - erythropoietin - treatment of anemia associated with chronic kidney disease (ckd).

ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - methoxy polyethylene glycol-epoetin beta 120 mcg / 0.3 ml - solution for injection - erythropoietin - treatment of anemia associated with chronic kidney disease (ckd).

ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - methoxy polyethylene glycol-epoetin beta 250 mcg / 0.3 ml - solution for injection - methoxy polyethylene glycol-epoetin beta - treatment of anemia associated with chronic kidney disease (ckd).

ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - granisetron as hydrochloride 1 mg - film coated tablets - granisetron - prevention of nausea and vomliting induced by cytostatic therapy.

ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - isotretinoin 20 mg - capsules - isotretinoin - for the treatment of severe cystic acne that does not respond to other treatment.

ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - isotretinoin 10 mg - capsules - isotretinoin - for the treatment of severe cystic acne that does not respond to other treatment.

ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - ceftriaxone as sodium 1000 mg/vial - powder and solvent for solution for injection - ceftriaxone - long-acting, broad spectrum cephalosporin, for the treatment of infections caused by susceptible organisms.

ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - ribavirin 200 mg - tablets - ribavirin - copegus in combination with peginterferon alfa 2a or interferon alfa - 2a is indicated in adult patients who are positive for serum hcv-rna, including patients with compensated cirrhosis . the combination with peginterferon alfa-2a is also indicated in patients co-infected with clinically stable hiv , including patients with compensated cirrhosis . copegus, in combination with peginterferon alfa-2a, is indicated in naive patients and patients who have failed previous treatment with interferon alpha (pegylated or non-pegylated) alone or in combination therapy with ribavirin.